SRPK Plasmids

SRPK (Serine/Arginine Protein Kinase) plasmids are molecular tools designed to study the expression, function, and regulation of SRPKs, a family of kinases that phosphorylate serine/arginine-rich (SR) proteins. SRPKs play a critical role in mRNA splicing, gene expression regulation, and other cellular processes, including cell cycle progression and stress responses. Dysregulation of SRPK activity is implicated in cancer, neurodegenerative diseases, and viral infections.

Content of SRPK Plasmids
  • SRPK Coding Sequence:
    • Encodes the full-length SRPK proteins, such as SRPK1 or SRPK2, or truncated forms for domain-specific studies.
  • Promoter:
    • Constitutive Promoters: (e.g., CMV, EF1α) for high and ubiquitous expression.
    • Inducible Promoters: (e.g., tetracycline-inducible systems) for controlled expression.
    • Tissue-Specific Promoters: For studying SRPK function in specific cell types or tissues.
  • Tagging Sequences:
    • Fusion tags (e.g., FLAG, GFP, or His6) for protein tracking, visualization, and purification.
  • Selectable Markers:
    • Antibiotic resistance genes (e.g., ampicillin, kanamycin) for plasmid selection in bacterial or mammalian cells.
Applications of SRPK Plasmids
  • Functional Domain Analysis:
    • Use plasmids encoding specific SRPK domains, such as the kinase domain, to dissect their functional roles.
  • Viral Replication Studies:
    • SRPKs play roles in viral life cycles, such as in hepatitis B virus (HBV) and human immunodeficiency virus (HIV). SRPK plasmids help study these interactions and identify antiviral targets.
  • Neurodegenerative Disease Research:
    • Investigate SRPK2’s involvement in neuronal apoptosis and neurodegenerative diseases like Alzheimer’s disease.
  • Subcellular Localization Studies:
    • Tagged SRPK plasmids enable visualization of SRPKs’ localization and dynamics within cells, particularly their shuttling between the cytoplasm and nucleus.
  • Gene Therapy Research:
    • Explore the therapeutic potential of modulating SRPK activity in diseases associated with aberrant splicing or SRPK dysregulation.

SRPK plasmids are powerful tools for studying the regulatory roles of SRPKs in mRNA splicing, signal transduction, and disease pathogenesis. These plasmids enable research into the molecular mechanisms of SRPK function and their therapeutic targeting in diseases such as cancer, viral infections, and neurodegeneration.

For Price Contact info@affigen.com 0.0 USD
AffiPLASMID® pEnCMV-HA-SRPK1 (human) -SV40-Neo
CAT# AFG-GNC-16507
Size: 1 Unit
For Price Contact info@affigen.com 0.0 USD
AffiPLASMID® pCMV-SRPK1 (human) -3×Myc-Neo
CAT# AFG-GNC-13190
Size: 1 Unit
For Price Contact info@affigen.com 0.0 USD
AffiPLASMID® pCMV-mCherry-SRPK1 (human) -Neo
CAT# AFG-GNC-11887
Size: 1 Unit
For Price Contact info@affigen.com 0.0 USD
AffiPLASMID® pCMV6-SRPK1-3*FLAG
CAT# AFG-GNC-8005
Size: 1 Unit
For Price Contact info@affigen.com 0.0 USD
AffiPLASMID® pEnCMV-HA-SRPK1-SV40-Neo
CAT# AFG-NVF-094059
Size: 2 μg
486.00 486.0 USD
AffiPLASMID® pBluescriptR-SRPK2
CAT# AFG-NVF-075262
Size: 2 μg
486.00 486.0 USD